As of Q4'25 (2025-12-31), CVS reported an EPS of 2.32 USD, representing a strong recovery from the previous quarter's negative EPS of -3.13 USD. Year-over-year EPS growth for Q4'25 stands at 77.10%, indicating a significant positive turnaround compared to prior quarters. Over the period from Q1'23 to Q4'25, CVS's EPS trend has been volatile, with notable fluctuations including sharp declines in Q1'24 (0.88 USD) and Q3'25 (-3.13 USD), as well as strong rebounds in Q3'23 (1.76 USD) and Q4'25 (2.32 USD). The YoY EPS growth line highlights these swings, with deep contractions in Q3'24 (-96.02%) and Q3'25 (-4571.43%), followed by robust growth in Q1'25 (60.23%) and Q4'25 (77.10%). This pattern suggests periods of operational or market challenges followed by substantial recoveries, reflecting a highly dynamic earnings environment for CVS over the observed quarters.